FAZIO, SERAFINO
 Distribuzione geografica
Continente #
AS - Asia 4.655
NA - Nord America 4.364
EU - Europa 3.853
SA - Sud America 467
AF - Africa 105
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 13.455
Nazione #
US - Stati Uniti d'America 4.204
SG - Singapore 2.395
RU - Federazione Russa 1.407
VN - Vietnam 737
CN - Cina 720
UA - Ucraina 652
IT - Italia 570
HK - Hong Kong 474
BR - Brasile 387
DE - Germania 294
FR - Francia 246
FI - Finlandia 205
SE - Svezia 118
GB - Regno Unito 114
CA - Canada 104
NL - Olanda 103
IE - Irlanda 69
IN - India 57
JP - Giappone 46
ZA - Sudafrica 33
MX - Messico 32
BD - Bangladesh 30
TR - Turchia 27
AR - Argentina 25
CI - Costa d'Avorio 25
ID - Indonesia 20
IQ - Iraq 18
TH - Thailandia 18
PH - Filippine 16
PK - Pakistan 15
PL - Polonia 15
KR - Corea 14
EC - Ecuador 13
TW - Taiwan 13
CO - Colombia 12
ES - Italia 12
VE - Venezuela 11
MA - Marocco 10
BE - Belgio 9
UZ - Uzbekistan 9
PY - Paraguay 8
BG - Bulgaria 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
SN - Senegal 5
AT - Austria 4
CL - Cile 4
IR - Iran 4
LT - Lituania 4
RO - Romania 4
TN - Tunisia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
HT - Haiti 3
IL - Israele 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BJ - Benin 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
GP - Guadalupe 2
JO - Giordania 2
KW - Kuwait 2
MG - Madagascar 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
GF - Guiana Francese 1
Totale 13.433
Città #
Singapore 955
Jacksonville 665
San Jose 578
Hong Kong 465
Moscow 362
Chandler 323
Beijing 214
Ho Chi Minh City 203
Ashburn 190
Hanoi 188
Princeton 178
Lauterbourg 169
The Dalles 155
Los Angeles 144
Santa Clara 135
Naples 104
Buffalo 103
Wilmington 97
Amsterdam 92
Nanjing 90
Dallas 88
Millbury 74
Ottawa 70
New York 48
Kronberg 46
Dublin 45
Tokyo 42
Nanchang 38
Orem 36
Boston 33
Redondo Beach 33
Haiphong 32
Norwalk 31
Shenyang 30
Munich 28
Da Nang 27
São Paulo 24
Hebei 23
Changsha 22
Council Bluffs 22
Bari 21
Chicago 20
Rome 20
Seattle 20
Jiaxing 19
Hefei 18
Mexico City 17
Milan 17
Biên Hòa 16
Denver 16
Frankfurt am Main 16
Brooklyn 15
Helsinki 15
Atlanta 14
Tianjin 14
Warsaw 14
Can Tho 13
Montreal 13
Bologna 12
Chennai 12
Orange 12
Johannesburg 11
Stockholm 11
Boardman 10
Des Moines 10
Elk Grove Village 10
Falls Church 10
Kunming 10
Phoenix 10
San Francisco 10
Belo Horizonte 9
Guangzhou 9
Karachi 9
Lawrence 9
Turin 9
Ankara 8
Hasselt 8
Houston 8
London 8
Poplar 8
Quito 8
Bangkok 7
Boydton 7
Cagliari 7
Campinas 7
Florence 7
Hải Dương 7
Mumbai 7
Porto Alegre 7
Rio de Janeiro 7
Salt Lake City 7
Tashkent 7
Baghdad 6
Caracas 6
Charlotte 6
Hangzhou 6
Jakarta 6
Napoli 6
Ninh Bình 6
Quận Ba 6
Totale 6.846
Nome #
Caso clinico Chilopericardio idiopatico: valutazione a distanza del trattamento chirurgico. 248
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 164
Impact of hyperthyroidism and its correction on vascular reactivity in humans. 163
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 139
Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. 138
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 137
Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. 130
Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure. 129
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 125
Cardiac effects of GH 125
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 125
Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure 124
Endocrine alterations are the main determinants of cardiac remodelling in restrictive anorexia nervosa 123
INCREASED ARTERIAL INTIMA-MEDIA THICKNESS IN CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY. 113
Effetti dell'associazione di policosanoli, lievito rosso e berberina sul metabolismo lipidico e la funzione endoteliale: studio randomizzato in doppio cieco controllato con placebo 113
Long term combination treatment for severe idiopathic pulmonary arterial hypertension 112
Cardiac function in patients with pacemaker: a noninvasive study. 111
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 108
Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation. 107
Fourier Analysis in patients with different pacing modes. 106
L'associazione di Valsartan 160 mg ed Idroclorotiazide 25 mg determina un efficace controllo della pressione arteriosa e migliora significativamente i parametri ecocardiografici, già dopo soli 3 mesi 106
[The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies] 105
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome 103
Prospective evaluation of hypertensive patients with carotid kinking and coiling: an ultrasonographic 7-year study. 101
Effycacy and safety of valsartan plus hydroclorothiazide for high blood pressure 100
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine 97
Insulin resistance: Is it time for primary prevention? 97
Tadalafil in Primary Pulmonary Arterial Hypertension 94
Follow-up of a respiratory rate modulated pacemaker. 93
The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril . 93
Platelet aggregability in patients with a VVI pacemaker. 91
Insufficienza cardiaca nell'obesità 91
Forum sulla ipertensione polmonare 91
A multicenter evaluation of a single-Pass Lead VDD pacing system. 89
Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function. 89
Efficacy of ticlopidine in the prevention of thromboembolic events in patients with VVI pacemakers. 88
Body composition, Bone metabolism, and heart structure and function in Growth hormone (GH) - Deficient adults before and after GH replacment therapy at low doses. 88
The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence. 88
Cardiac structural and functional abnormalities in adul patient with Growth hormone deficiency. 84
Il Canrenoato di potassio nella terapia dello scompenso cardiaco. Valutazione emodinamica. 83
Il captopril nel trattamento a lungo termine dell'ipertensione arteriosa: efficacia e tollerabilità. 83
Effects of thyroid hormone on the cardiovascular system 82
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. 82
Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. 81
Atenololo e ipertensione: confronti e associazioni 81
Letter by Fazio and Carlomagno regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population". 81
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. 80
Possibilità diagnostiche della stimolazione cardiaca transesofagea e della ventricolografia radioisotopica nella sindrome di Wolf-Parkinson-White. 80
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 80
Effects of subclinical thyroid dysfunction on the heart. 79
Subclinical hypothyroidism and cardiac function. 79
La funzione ventricolare sinistra nella stimolazione programmabile. 79
Supraphysiological doses of GH induce rapid changes in cardiac morphology and function. 78
An exaggerated systolic blood pressure response to exercise is associated with cardiovascular remodeling in subjects with prehypertension. 78
Attività Antiaterogenica di un’Associazione di Nutraceutici: Studio Randomizzato e Controllato con Placebo. 78
Esperienza Clinica con pacemaker monocatetere VDD Phymos. 77
Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. 75
Prehypertension and elevated risk of cardiovascular disease: physiopathologic mechanisms. 75
Valutazione dell'NT-proBNP come marker di disfunzione cardiaca nella stratificazione del rischio dei pazienti con insufficienza cardiaca 75
Exercise and Women's Healt 75
Thyroid Hormones and Cardiovascular System: From Bench to Bedside 75
Effects of thyroid hormone on cardiac function : the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. 73
Aldosterone receptor blockade in the management of heart failure 73
Benefits of rate responsive ventricular pacing in patients with chronic atrial fibrillation and low ventricular response. 73
Prazosina ed atenololo nel trattamento dell'ipertensione arteriosa: confronto e associazione 73
Rate responsive pacing guided by respiratory rate. Long term results. 72
L'atenololo nella terapia dell'angina pectoris:valutazione mediante test da sforzo al treadmill. 72
Cardiovascular aspects in acromegaly: effects of treatment. 71
Growth Hormone and the heart 71
Immunodeficienze e malattie immuno-mediate 71
Aldosterone receptors' blockade in the management of heart failure in elderly patients. 71
Impaired cardiac performance is a distinct feature of uncomplicated acromegaly 71
Atenolol and atrial fibrillation: evaluation by systolic time intervals. 70
Aterosclerosi carotidea ed ictus aterotrombotico. Attuali prospettive diagnostiche e terapeutiche. 70
L'Arterosclerosi 70
Il bisoprololo nella terapia dell'angina pectoris: confronto in doppio cieco con verapamile. 69
Cardiovascular Safety of Acute Recombinant Human Thyrotropin Administration to Patients Monitored for Differentiated Thyroid Cancer. 69
Ruolo dell’asse GH/IGF-I nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale. 69
atenolol and methyldopa in the treatment of mild moderate hypertension: a double blind comparison and combination with single doses. 68
Acebutololo e nifedipina nella terapia dell'ipertensione arteriosa. 68
Endocardite reumatica e malattie delle valvole cardiache. 67
Risultati a lungo termine del trattamento con Ticlopidina in pazienti con pacemaker permanente. 67
Efficacia antiaritmica e tollerabilità della Mexiletina slow release in confronto con la Idrochinidina ritardo. 67
Late onset of hypoxemia due to a pulmonary arteriovenous malformation during selective estrogen receptor modulator therapy. 67
Benefits of rate responsive ventricular pacing in patients with chronic atrial fibrillation and low ventricular response. 66
Esperienza clinica con Activitrax. 66
L'organizzazione del laboratorio di elettrofisiologia degli anni 90. 66
Diagnosi precoce di un caso di endomiocardiopatia eosinofila di Loeffler. Clinica ed Emodinamica. 65
L'Approccio terapeutico all'ipertensione arteriosa: confronto ed associazioni dell' acebutololo con nifedipina e captopril. 65
L'adattamento emodinamico nell'obesita' di grado elevato associata o meno a ipertensione arteriosa. 65
Heart failure caused by dilated cardiomyopathy: rationale for treatment with growth hormone. 65
Risultati a medio e lungo termine del trattamento chirurgico isolato dell'arteria coronarica discendente anteriore:a proposito di 81 casi. 64
Il controllo e la programmazione dei moderni pacemaker. 63
Cardiac function and sympathetic activity in young diabetics. 63
Ormone della crescita e cuore. 63
Growth hormone as a potential future therapy for congestive heart failure. 63
Monitoring of antitumoral effect and cardiac toxicity of Antracyclines in advances breast cancer. 63
Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function 63
Endogenous subclinical hyperthyrfoidism affects quality of life and cardiac morphology and function in young and middle-aged patients. 61
L'ischemia miocardica: un problema diagnisrico nei pazienti con pacemaker. La scintigrafia miocardica con test di incremento della frequenza di pacing. 61
Totale 8.798
Categoria #
all - tutte 47.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/2022525 11 2 6 5 10 21 3 39 42 44 184 158
2022/2023893 191 52 27 64 105 80 14 60 155 94 39 12
2023/2024609 27 93 82 26 40 32 16 92 8 7 122 64
2024/20253.311 262 256 44 32 53 102 427 150 373 365 976 271
2025/20265.677 712 426 523 394 978 265 611 423 831 328 118 68
Totale 13.569